Stepan Company

NYSE:SCL 주식 보고서

시가총액: US$1.7b

Stepan 과거 수익 실적

과거 기준 확인 1/6

Stepan의 수입은 연평균 -14.3%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 9.8%의 비율로 증가했습니다. 매출은 연평균 6.2%의 비율로 증가해 왔습니다. Stepan의 자기자본이익률은 3.8%이고 순이익률은 2.1%입니다.

주요 정보

-14.3%

수익 성장률

-14.1%

EPS 성장률

Chemicals 산업 성장12.9%
매출 성장률6.2%
자기자본 수익률3.8%
순이익2.1%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Recent updates

Stepan's (NYSE:SCL) Upcoming Dividend Will Be Larger Than Last Year's

Nov 02
Stepan's (NYSE:SCL) Upcoming Dividend Will Be Larger Than Last Year's

Stepan Company: Not A Great Performance, But Good Value

Oct 30

Some Investors May Be Worried About Stepan's (NYSE:SCL) Returns On Capital

Aug 30
Some Investors May Be Worried About Stepan's (NYSE:SCL) Returns On Capital

Stepan (NYSE:SCL) Takes On Some Risk With Its Use Of Debt

Aug 17
Stepan (NYSE:SCL) Takes On Some Risk With Its Use Of Debt

Stepan Company Is Making Great Progress

Jul 28

When Should You Buy Stepan Company (NYSE:SCL)?

Jul 24
When Should You Buy Stepan Company (NYSE:SCL)?

There Are Reasons To Feel Uneasy About Stepan's (NYSE:SCL) Returns On Capital

May 29
There Are Reasons To Feel Uneasy About Stepan's (NYSE:SCL) Returns On Capital

Stepan Company's (NYSE:SCL) Price In Tune With Earnings

Apr 05
Stepan Company's (NYSE:SCL) Price In Tune With Earnings

Is There Now An Opportunity In Stepan Company (NYSE:SCL)?

Mar 22
Is There Now An Opportunity In Stepan Company (NYSE:SCL)?

Is Stepan (NYSE:SCL) Using Too Much Debt?

Feb 18
Is Stepan (NYSE:SCL) Using Too Much Debt?

Stepan Company: It's Wise To Remain Cautious

Feb 17

With Stepan Company (NYSE:SCL) It Looks Like You'll Get What You Pay For

Jan 04
With Stepan Company (NYSE:SCL) It Looks Like You'll Get What You Pay For

Capital Allocation Trends At Stepan (NYSE:SCL) Aren't Ideal

Dec 17
Capital Allocation Trends At Stepan (NYSE:SCL) Aren't Ideal

Are Investors Undervaluing Stepan Company (NYSE:SCL) By 27%?

Dec 05
Are Investors Undervaluing Stepan Company (NYSE:SCL) By 27%?

Stepan Company: An Unfortunate Development Resulting In An Upside

Dec 03

When Should You Buy Stepan Company (NYSE:SCL)?

Oct 16
When Should You Buy Stepan Company (NYSE:SCL)?

Stepan Company: Don't Try To Catch The Falling Knife, Still Potentially Overvalued

Sep 17

Stepan (NYSE:SCL) Has A Somewhat Strained Balance Sheet

Aug 31
Stepan (NYSE:SCL) Has A Somewhat Strained Balance Sheet

Stepan's Shares Are Reaching Even More Appealing Prices

Aug 28

Are Investors Undervaluing Stepan Company (NYSE:SCL) By 31%?

Jul 18
Are Investors Undervaluing Stepan Company (NYSE:SCL) By 31%?

Investors Could Be Concerned With Stepan's (NYSE:SCL) Returns On Capital

Jul 06
Investors Could Be Concerned With Stepan's (NYSE:SCL) Returns On Capital

Stepan Company: A Downward Revision Is Warranted

Jun 09

Is Stepan (NYSE:SCL) Using Too Much Debt?

May 23
Is Stepan (NYSE:SCL) Using Too Much Debt?

At US$92.20, Is Stepan Company (NYSE:SCL) Worth Looking At Closely?

May 01
At US$92.20, Is Stepan Company (NYSE:SCL) Worth Looking At Closely?

Stepan (NYSE:SCL) Ticks All The Boxes When It Comes To Earnings Growth

Mar 25
Stepan (NYSE:SCL) Ticks All The Boxes When It Comes To Earnings Growth

Returns On Capital At Stepan (NYSE:SCL) Have Stalled

Mar 08
Returns On Capital At Stepan (NYSE:SCL) Have Stalled

Stepan Q4 2022 Earnings Preview

Feb 15

Here's Why Stepan (NYSE:SCL) Can Manage Its Debt Responsibly

Feb 02
Here's Why Stepan (NYSE:SCL) Can Manage Its Debt Responsibly

Stepan Company (NYSE:SCL) Shares Could Be 30% Below Their Intrinsic Value Estimate

Jan 05
Stepan Company (NYSE:SCL) Shares Could Be 30% Below Their Intrinsic Value Estimate

Stepan Company: Expect Outperformance To Continue

Jan 03

수익 및 비용 분석

Stepan 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

NYSE:SCL 수익, 비용 및 수입 (USD Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 242,1874615357
30 Jun 242,2023514758
31 Mar 242,2263814458
31 Dec 232,3264014659
30 Sep 232,4215214260
30 Jun 232,5787915763
31 Mar 232,74911815965
31 Dec 222,77314715167
30 Sep 222,75615315567
30 Jun 222,64015114466
31 Mar 222,48414214864
31 Dec 212,34613815963
30 Sep 212,23115116362
30 Jun 212,09214716861
31 Mar 211,95814016859
31 Dec 201,87012715458
30 Sep 201,82011814656
30 Jun 201,80711114256
31 Mar 201,82010613955
31 Dec 191,85910315555
30 Sep 191,88010514153
30 Jun 191,93710114654
31 Mar 191,98410413954
31 Dec 181,99411113454
30 Sep 182,0019714355
30 Jun 181,9819713453
31 Mar 181,9569214054
31 Dec 171,92510113654
30 Sep 171,8729013954
30 Jun 171,8299014756
31 Mar 171,7899014656
31 Dec 161,7668615056
30 Sep 161,7659115156
30 Jun 161,7649413754
31 Mar 161,7628314152
31 Dec 151,7767613850
30 Sep 151,8116912347
30 Jun 151,8595812946
31 Mar 151,9106511345
31 Dec 141,9275710945
30 Sep 141,9476211747
30 Jun 141,9316811648
31 Mar 141,9026712047
31 Dec 131,8817312447

양질의 수익: SCL 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: SCL 의 현재 순이익 이익률 (2.1%) 작년보다 낮습니다 (2.2%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: SCL 의 수입은 지난 5년 동안 매년 14.3% 씩 감소했습니다.

성장 가속화: SCL 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.

수익 대 산업: SCL 은 지난 1년 동안 마이너스 수익 성장( -12.3% )을 기록하여 Chemicals 업계 평균( -0.5% ).


자기자본 수익률

높은 ROE: SCL 의 자본 수익률( 3.8% )은 낮음으로 간주됩니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기